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ABSTRACT 
Type 2 diabetes is a disease with increasing prevalence. Better knowledge of risk 
factors may form the bases for specific interventions and preventive measures. The aim 
of this thesis was to contribute to the knowledge on type 2 diabetes, by examining 
family history of diabetes and other risk factors with emphasis on psychological 
exposures.  
 
The studies are based on the cohort of the Stockholm Diabetes Prevention Program 
(SDPP) in which 12,952 men and 19,416 women 35-56 years old were screened for 
diabetes and diabetes in close relatives. The baseline health examination comprised 
3,128 men and 4,821 women of whom 50% had a family history of diabetes. An oral 
glucose tolerance test identified 65 men and 63 women with previously undiagnosed 
diabetes, and 228 men and 208 women with pre-diabetes (IFG, IGT or IFG+IGT). At 
the follow-up 8-10 years later, 2383 men and 3329 women were re-examined. 183 men 
and 106 women were then classified with diabetes, and 291 men and 211 women with 
pre-diabetes. In study IV, diabetes was assessed according to filled prescriptions of 
anti-diabetic drugs 2005-2008, through record linkage to the Swedish Prescribed Drug 
Register. The health examinations included body measurements, and information was 
obtained by questionnaire on life style, psychosocial, personality and socioeconomic 
factors. Prevalence odds ratios (OR) with 95% confidence intervals (CI) were 
calculated in logistic regression analyses for cross-sectional and prospective studies.  
 
Our findings indicate that a family history of diabetes is an important risk factor in both 
men and women. A combined exposure to a family history of diabetes and another risk 
factor, such as obesity, physical inactivity, smoking or low sense of coherence 
(capacity to cope with stressors) had a greater effect on type 2 diabetes than any of 
these factors alone. Biologic interaction was not suggested, with the exception for the 
combination of a family history of diabetes and obesity in women with pre-diabetes. 
High psychological distress conferred a two-fold increased risk for type 2 diabetes and 
pre-diabetes in men, and in women middle scores were associated with an almost two-
fold increase of pre-diabetes. Among personality traits, low antagonism in men was 
associated with a reduced risk of having abnormal glucose regulation (pre-diabetes or 
type 2 diabetes), as were high hedonic capacity in both men and women. No significant 
associations were found with the impulsivity, negative affectivity, and alexithymia 
scales. Non-response bias did not seem to be present at screening- and baseline steps 
indicating that diabetes prevalence and risk may be estimated from a cohort study such 
as the SDPP. At follow-up, the overall risk for diabetes was slightly lower in the study 
group, although the effect of this for the association studies was limited. 
 
In conclusion, a combined exposure to a family history of diabetes and lifestyle factors 
had greater effect on type 2 diabetes than any of these factors alone. There was no 
cross-sectional biologic interaction between studied risk factors, except for a family 
history of diabetes and obesity in women with pre-diabetes. Psychological distress 
seems to be involved in the aetiology of type 2 diabetes, at least for men. In addition, 
some personality traits may be associated with abnormal glucose regulation.  
 
Keywords: cohort, family history of diabetes, lifestyle, personality, psychological 
distress, screening, type 2 diabetes 
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1 BACKGROUND 
 
 
1.1 TYPE 2 DIABETES 
 
1.1.1 Definition and description 
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia. The 
chronically elevated blood glucose levels of diabetes in conjunction with other 
metabolic disturbances, i.e. dyslipidemia, are associated with long-term damage, 
dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, 
and blood vessels1. Diabetes increases the risk for stroke or myocardial infarction four 
to six times2.  
 
The vast majority of diabetes cases fall into two categories: Type 1 diabetes, where the 
cause is an absolute deficiency of insulin secretion, and type 2 diabetes, where the 
cause is a combination of insulin resistance which decreases the ability of the liver, 
skeletal muscle and adipose tissue to respond to insulin, and inadequate compensatory 
insulin secretion from the β-cells of the pancreas3. Type 2 diabetes often develops 
insidiously through asymptomatic pre-stages, where a degree of hyperglycemia 
sufficient to cause pathologic and functional changes in various target tissues may be 
present long before diabetes is diagnosed. Individuals having a pre-stage of diabetes 
have a higher risk of developing diabetes1. Also prior gestational diabetes, i.e. elevated 
blood glucose levels during pregnancy, increases the risk for later type 2 diabetes3. 
Type 2 diabetes accounts for 85-95% of all diabetes cases1. Latent autoimmune 
diabetes in adults (LADA) is a form of diabetes in between type 1 and type 2 diabetes 
with a prevalence of approximately 5-10% among adults with non-insulin-requiring 
diabetes. It is a slowly progressive form of autoimmune or type 1 diabetes with onset in 
adult age, and that can be treated initially without insulin injections4. 
 
 
1.1.2 Occurrence 
The prevalence of type 2 diabetes varies greatly between different parts and populations 
of the world, ranging from approximately 3-4% in Sub-Saharan Africa5 to up to 38-
50% among Pima Indians in North America6,7. The prevalence of diabetes in Sweden is 
still relatively low and has been estimated to about 3-5%2,8,9. Both stable10,11 and 
increased12,13 prevalences in Sweden have been reported recently. One component 
behind increased prevalence is the improved survival of patients14. It should be noted 
though, that among non-European immigrants being 60 years of age and living in 
Stockholm, the prevalence has been estimated to 14.6%, twice the prevalence in the 
Swedish-born subjects, 6.9%15 .  
 
The number of people with diabetes is increasing globally due to population growth, 
aging, urbanization and increasing obesity and physical inactivity16. The most dramatic 
increase in the prevalence of diabetes is seen in developing and newly developed 
nations, particularly in the Pacific and Indian Ocean region, and Asia, as a result of 
industrialization and westernalization of lifestyles (including high-energy diets and 
reduced physical activity). The increased prevalence of diabetes is also seen in 
disadvantaged communities in developed nations, e.g. native Americans, Afro-
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Americans and Mexican Americans in the USA, native Canadians, Australian 
Aboriginies and Torres Strait islanders, and Polynesians in New Zealand17. Certain 
populations have a high propensity for type 2 diabetes implicating a genetic 
susceptibility which in combination with changed life circumstances results in 
increasing prevalence of the disease6,18.  
 
The total number of people with diabetes across the world will increase from 285 
million in 2010 to 439 million in 2030 in one projection which is based on population 
aging and urbanisation. The three countries with highest numbers of estimated cases of 
diabetes for 2010 and 2030 are India, China and U.S., and highest prevalence has 
Nauru, United Arab Emirates, and Saudi Arabia/Mauritius5. Also the increase in 
obesity is considered epidemic18,19.  
 
Besides that diabetes reduces quality of life for individuals and families, the direct and 
indirect costs associated with diabetes and diabetes related complications will put a 
heavy burden on the society20,21.  
 
 
1.2 RISK FACTORS 
Type 2 diabetes is a complex disease of multiple aetiology which has both genetic and 
environmental components. Type 2 diabetes is regarded to be triggered by 
environmental factors in genetically susceptible individuals22 . 
 
 
1.2.1 Genetic factors and family history of diabetes 
Type 2 diabetes has a clear familial component and this is a result of both shared 
environmental effects and genes22. The risk is increased in individuals with affected 
first-degree relatives. A family history of diabetes has been reported to increase the risk 
2-4-fold in low-prevalence populations23-25. The details of the genetic influence of type 
2 diabetes remain to be fully understood. At this point, more than 36 diabetes-
associated genes primarily involving β-cell dysfunction has been identified in genome-
wide association studies. However, only around 10% of the heritability can be 
explained by these genes, each of them having a small influence and representing 
common variants in multiple gene loci26. The high prevalence of type 2 diabetes in 
certain populations has sometimes been ascribed to a “thrifty” genotype. This genotype 
is believed to offer a survival advantage in early societies by favouring fat deposit 
during periods when food was abundant, to better survive times of famine27,28, 
however, this has not directly been proved28.  
 
 
1.2.2 Environmental factors 
 
1.2.2.1 Obesity 
Obesity is the most prominent environmental risk factor for developing type 2 
diabetes29. However, obesity is, like type 2 diabetes, also influenced by genetics30 . The 
duration of obesity plays a role22,31. It has been shown that different measures of body 
size; BMI, waist circumference, and waist-to-hip ratio all are associated with type 2 
diabetes32. In obese individuals, the adipose tissue releases increased amounts of non-
esterified fatty acids, glycerol, hormones, pro-inflammatory cytokines and other factors 
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which are involved in the development of insulin resistance. When insulin resistance is 
accompanied by dysfunction of pancreatic islet β-cells, failure to control blood glucose 
levels follows33,34. It is important to note that not all obese individuals develop type 2 
diabetes, and also non-obese individuals develop type 2 diabetes22. Other factors must 
be involved.  
 
Interaction effects between abdominal obesity and hyperglycemia have been reported 
where the association between abdominal obesity and hyperglycemia was stronger in 
the presence of a parental history of diabetes, in addition to that the individuals with a 
parental history of diabetes were more obese35. Also, biologic interaction between 
family history of diabetes and obesity has been suggested36. Otherwise, little is known 
regarding the possible presence of biologic interaction effects between different risk 
factors influencing the risk of type 2 diabetes. Biologic interaction implies that the joint 
effect of two risk factors is greater than the sum of the independent effects37. With 
prevention in focus synergy effects is an important field of study. If biologic interaction 
is being present between two factors, this would imply that the elimination of one risk 
factor also reduces the risk of the other38.  
 
1.2.2.2 Health behaviours 
Physical inactivity39,40 and tobacco use41-42 confers an increased risk for type 2 diabetes. 
Coffee consumption has been associated with decreased risk43 while consumption of 
alcoholic drinks, depending on reported amounts of intake, can either decrease or 
increase the risk of developing diabetes44. 
 
1.2.2.3 Socioeconomic factors 
In western societies, type 2 diabetes is more prevalent in lower socioeconomic groups 
and materially deprived areas45-47 . This can partly be attributed to that certain risk 
factors are being more prevalent, i.e. obesity, smoking, and sedentary lifestyles48,49 . 
Recently, the incidence of type 2 diabetes was reported to be associated with a low 
socioeconomic position whether measured by educational level, occupation or income 
in high-, middle, and low-income countries, although data from middle- and low-
income countries were limited50. In Sweden, about 20% of the burden of type 2 
diabetes can be attributed to low education levels51. Also, within civil servants a social 
gradient measured by employment grade has been observed for incident diabetes52. 
 
1.2.2.4 Psychosocial stress and depressive symptoms 
The notion that mental or emotional stress can contribute to the aetiology of diabetes 
mellitus can be tracked back at least 300 years. And by the end of the 19th century, 
William Maudsley, considered by many to be the founder of modern psychiatry, wrote 
that diabetes is sometimes caused in man by mental anxiety. He had observed that 
diabetes often followed the occurrence of a sudden trauma53.  
 
Although the literature is not extensive, a variety of concepts related to stress or 
emotional stress, and sleep problems have been studied in relation to type 2 diabetes. In 
one study major stressful life events were related to the prevalence of type 2 diabetes, 
and accumulating of visceral fat did not explain this association54. Low decision 
latitude at work and low sense of coherence has been associated to type 2 diabetes in 
women55. In the same study, high demands at work showed no association with type 2 
diabetes. In another study of different psychosocial factors in civil servants52 only 
effort-reward imbalance, in men, was associated with type 2 diabetes. Furthermore, 
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depressive symptoms or disorder have been prospectively related to type 2 diabetes 
56,57. Also associations between sleep disturbances and incidence of diabetes have been 
reported58,59, although not all studies found an association60. 
 
In 2006, a meta-analysis was published compiling the results of the nine available 
prospective studies published between 1996 and 2004 on depression as a risk factor for 
type 2 diabetes mellitus61. A somewhat increased risk for type 2 diabetes in depressed 
individuals was reported, pooled relative risk 1.37 (1.14-1.63). The studies compiled in 
the meta-analysis used a variety of instruments for measuring depression which may 
have influenced the results, and the authors pointed to the need for further exploring the 
influence of depressive symptoms on type 2 diabetes61. 
 
The biological mechanisms involved in the associations between stress and type 2 
diabetes may embrace that stress contributes to hyperglycemia, possibly through 
activation of the sympathetic nervous system and the HPA-axis. Activation of the 
HPA-axis causes excessive cortisol production, which may lead to long-term 
consequences such as insulin resistance, dyslipidaemia, visceral obesity and type 2 
diabetes62-63. Also immunological processes have been proposed64-66. 
 
1.2.2.5 Personality 
Hostility and anger have been associated to blood glucose and insulin levels67-69 , 
abdominal obesity70 and type 2 diabetes71. Also, hostility and anger have been reported 
to be risk factors for cardiovascular disease72,73 which partly share aetiology with type 2 
diabetes74. Anxiety is suggested to predict73, and negative affect has shown a weak 
association to coronary heart disease75. It may be noted that concepts such as 
anger/hostility or anxiety may generally be referred to in the literature somewhat 
differently, such as personality traits, behaviour, emotions or emotional stress. Hostility 
and anger have been studied in relation to type 2 diabetes to a limited extent, and even 
less is known about if other personality traits influence the risk of type 2 diabetes. 
Hypothetically, the same mechanisms as proposed for depression including hormonal 
arousal in response to stress could be responsible for possible influences on type 2 
diabetes risk62,63.  
 
Trait theory is a specific field in personality psychology that deals with individual 
differences. Personality traits refer to consistent patterns in the way individuals behave, 
feel and think. There is no single trait theory, however most scientists in this field 
believe that inherited biological factors are primary determinants of individual 
differences in traits. The paramount interest of trait researchers is measurement, and a 
trait taxonomy is an overall descriptive scheme within which any and all persons can be 
described. A large body of research involving factor analyses indicates that five major 
factors are necessary and reasonably sufficient for a taxonomy of individual 
differences. Interestingly, individual words that describe persons in the everyday 
language, were the starting point from which the five-factor model of personality was 
developed76.  
 
The five major personality factors are called: Neuroticism, that contrasts emotional 
stability with a broad range of negative feelings, including anxiety, sadness, irritability, 
and nervous tension. Openness to experience, which describes the breadths, depth, and 
complexity of an individual’s mental and experiential life. Extraversion and 
agreeableness, that both summarizes the traits that are interpersonal; that is, they 
capture what people do with each other and to each other. Finally, conscientiousness, 
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which primarily describes task- and goal-directed behaviour and socially required 
impulse control76. The text in this and the previous paragraph was compiled from 
information in Personality: Theory and research, by Cervone & Pervin, 2008. 
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2 AIMS 
 
 
The general aim of this thesis was to contribute to the understanding of the aetiology of 
type 2 diabetes, by examining family history of diabetes and other risk factors, with 
emphasis on psychological exposures. In addition, the objective was to consider some 
methodological aspects relevant for observational studies including diabetes cohort or 
screening studies. 
 
The specific aims of the individual papers were: 
 
Study I: To investigate the influence of family history of diabetes, body mass index, 
smoking, physical inactivity, and sense of coherence and to evaluate if family history of 
diabetes acts in biological synergy with these exposures to influence pre-diabetes or 
type 2 diabetes.  
 
Study II: To estimate the role of self-reported psychological distress, including 
symptoms of anxiety, apathy, depression, fatigue and insomnia, as a predictor of pre-
diabetes and type 2 diabetes. 
 
Study III: To examine personality traits antagonism, impulsivity, hedonic capacity, 
negative affectivity and alexithymia in association with abnormal glucose regulation. 
 
Study IV: To evaluate potential selective non-response or non-participation at the 
screening-, baseline-, and follow-up steps of Stockholm Diabetes Prevention 
Programme. Also, to analyse if our previous association studies have resulted in false 
risk estimates for type 2 diabetes associated with different exposures.  
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3 MATERIAL AND METHODS 
 
 
3.1 STUDY DESIGN  
The studies in the present thesis are based on the population-based cohort of Stockholm 
Diabetes Prevention Programme (SDPP). 
 
 
3.1.1 Baseline study 
A short questionnaire was sent to all men born 1938-1957 living in Sigtuna, Tyresö, 
Upplands Bro and Värmdö in Stockholm and all women born 1942-1961 living in the 
same municipalities and one additional municipality; Upplands Väsby, asking about 
country of birth and presence of diabetes in subjects and in relatives (Fig. 1). The study 
population was identified through the Stockholm County Council Register. Answers 
were obtained from 79% (10236/12952) of men and 85% (16481/19416) of women. 
Individuals were excluded due to diabetes (2.5% men and 1.5% women), foreign origin 
(2.1% men and 7.6% women), family history of diabetes (FHD) that was unclear 
(27.4% men and 28.5% women) and insufficient FHD (15.0% men and 9.9% women). 
A restriction in the female sample had to be done due to financial reasons which 
excluded 35- to 44-year-old subjects born in the last third of each month. 
 
At a second step, subjects with FHD together with subjects randomly selected among 
those without FHD, matched to the first group by age and municipality, were invited to 
a health examination. In total, 3162 (69.8%) men and 4946 (70.3%) women accepted 
the invitation. FHD was self-reported by the subjects and defined as known diabetes in 
at least one first degree relative (parent or sibling) or at least two second-degree 
relatives (grandparents, uncles or aunts), with diabetes onset generally at the age above 
35 years (less than 6% were below 35 years). The sample was enriched to 50% with 
subjects having a family history of diabetes (FHD). 
 
The participants underwent a standardised oral glucose tolerance test (OGTT), body 
measurements and answered an extensive questionnaire about smoking habits, physical 
activity, diet, socioeconomic and psychosocial factors. Uncertain heredity, incomplete 
examinations and (for women) pregnancy, breast-feeding and medical reasons excluded 
34 men and 125 women. Thus, the final baseline study group comprised 3128 men and 
4821 women. 
 
 
3.1.2 Follow-up study 
After 8-10 years, the baseline study sample was again invited to a health examination. 
Subjects diagnosed with type 2 diabetes at baseline, 65 men (2.1%) and 63 women 
(1.3%), were excluded together with subjects who had moved outside Stockholm 
County, 239 men (7.6%) and 333 women (6.9%). In total 78 men (2.5%) and 60 
women (1.2%) had died during the follow-up period. Of the remaining 2746 men and 
4365 women who received an invitation, 2385 men (86.9%) and 3336 women (76.4%) 
went through a health examination the same as on the baseline occasion. Participants 
diagnosed with diabetes during the follow-up period did not undergo the OGTT. A 
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fasting blood sample was taken and also information on year of diagnosis and type of 
treatment. 
 
In total, 361 men (13.1%) and 1029 women (23.6%) did not wish to participate or 
could not be reached. After the examinations two men and seven women were excluded 
due to reporting type 1 diabetes, not answering the questionnaire or because efforts to 
take a blood sample had failed. The total follow-up study group then comprised 2383 
men and 3329 women, representing 76.2% and 69.1% respectively, of the baseline 
study population.  
 
All subjects gave informed consent and the study was approved by the ethics 
committee of Karolinska University Hospital.
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Figure 1 Study design of Stockholm Diabetes Prevention Programme 
Postal questionnaire to all men and women 35-55 
years, residing within 5 municipalities in Stockholm 
Men: 12,952  Women: 19,416
Responders: 
Men: 10,236 (79%) 
Women: 16,481 (85%) 
No FHD 
Men: 3,329 
Women: 4,296
FHD 
Men: 2,106 
Women: 3,583
Gestational 
diabetes 
Women: 424 
Age-adjusted sample 
Men: 2,424 
Women: 3497 
Excluded 
Men: 4,801 (47%) 
Women: 8,178 (50%)
Health examination 1: 
- Oral glucose tolerance test 
- Body measurements 
- Questionnaire 
Baseline study group 
Men: 3,128 Women: 4,821 
FHD: 52% FHD: 54% 
Invitation letter to baseline study 
group 
Men: 2,746 Women:4,365 
Health examination 2: 
- Oral glucose tolerance test 
- Body measurements 
- Questionnaire 
Follow-up study group 
Men: 2,383  Women: 3,329 
FHD: 57%  FHD: 58% 
Excluded 
Men: 33 
Women: 129
Excluded 
Women: 466 
Excluded 
Men: 2 
Women: 7
Excluded 
Men: 382 
Women:456
Baseline study 
Men 1992-94 
Women 1996-98 
Follow-up study 
Men 2002-04 
Women 2004-06 
Follow-up period 
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3.2 CLASSIFICATION OF GLUCOSE TOLERANCE 
Classification of glucose tolerance according to the OGTT followed the WHO criteria 
from 199877. An individual was classified as having normal glucose tolerance (NGT), 
when the fasting plasma glucose level was <6.1 mmol/l and the 2-h plasma glucose 
level was <7.8 mmol/l. Impaired fasting glucose (IFG) referred to a fasting plasma 
glucose value of 6.1-6.9 mmol/l, and a 2-hour value of <7.8 mmol/l. Impaired glucose 
tolerance (IGT) corresponded to a fasting plasma glucose level of <6.1 mmol/l and a 2-
h value of 7.8-11.0 mmol/l. Impaired fasting glucose+impaired glucose tolerance 
(IFG+IGT) referred to a fasting plasma glucose value of  6.1-6.9 mmol/l and a 2-h 
value of 7.8-11.0 mmol/l. Type 2 diabetes was classified when the fasting plasma 
glucose value was ≥7.0 mmol/l and/or the 2-h plasma glucose value was ≥11.1 mmol/l. 
IFG, IGT and IFG+IGT are referred to as “pre-diabetes”. Also, pre-diabetes+type 2 
diabetes are referred to as “abnormal glucose regulation”. In the analyses, the subjects 
with normal glucose tolerance were treated as the reference group.  
 
 
3.3 CLASSIFICATION OF DRUG-TREATED DIABETES 
Drug-treated diabetes was defined as having filled at least one prescription of anti-
diabetic drugs including insulin (ATC code A10 with subgroups) during the time 
period between July 1, 2005 and November 30, 2008, registered in the Swedish 
Prescribed Drug Register at the National Board of Health and Welfare. The individuals 
that had not filled any prescription of anti-diabetic drugs were treated as the reference 
group.  
 
 
3.4 MEASUREMENT OF EXPOSURES AND POTENTIAL CONFOUNDERS 
 
3.4.1 Body measurements and health behaviours 
Weight and height was registered with the subjects wearing light indoor clothes and no 
shoes. Waist and hip circumferences were measured with the subject lying down. Body 
mass index was calculated and categorised as <25.0 (normal weight), 25.0-29.9 
(overweight) and ≥30 (obesity) kg/m². In paper 1 BMI was dichotomised in two ways: 
<25.0 vs ≥25.0, i.e. normal weight vs overweight (including obesity); and <30.0 vs 
≥30.0, i.e. non-obesity vs obesity.  
 
3.4.1.1 Physical activity 
Physical activity was assessed with the question “How physically active have you been 
during your leisure time during the last year?” The four response options corresponded 
to: 1) sedentary leisure time, 2) moderate activity, 3) moderate regular activity, and 4) 
regular exercise and training. In the analyses the answering alternatives were 
categorized as low, moderate or regular physical activity according to answering 
alternatives 1, 2 and 3 + 4, respectively. In paper 1, the answers were dichotomised to 
either physically inactive according to response alternative 1 or physically active 
according to alternative 2-4. 
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3.4.1.2 Smoking 
Smoking status was based on information in the questionnaire on current and former 
smoking habits. Subjects were classified in three groups: never, former and current 
users. In paper I subjects were classified in two groups: current users or non-current 
users (including never and former users). 
 
 
3.4.2 Socioeconomic position 
Socio-economic position (SEP) was based on self-reported occupational titles and 
classified according to the standard system elaborated by Statistics Sweden78. Analyses 
were performed in four groups, high (high- and medium-level nonmanual employees), 
middle (low-level nonmanual employees) low (unskilled and skilled manual workers) 
and self-employed/farmers. 
 
 
3.4.3 Psychosocial measures 
 
3.4.3.1 Sense of coherence 
Sense of coherence (SOC) is an instrument measuring the ability to cope with life 
stressors. The theory and instrument was developed by Antonovsky79. The original 
instrument is based on 29 items on the three dimensions comprehensibility, 
meaningfulness and manageability79. Our analysis of SOC is based on three questions 
according to a simplified method of measurement suggested to capture the essence of 
the three dimensions and being adequately valid80. The three response alternatives gave 
one, two or three points, and a summed index of the three items was created. SOC was 
categorised as low (low) or high (lower middle, upper middle, high) according to the 
distribution of responses among all respondents.  
 
3.4.3.2 Psychological distress 
Psychological distress was measured by an index composed of five items in the 
questionnaire. The question “How often during the latest twelve months have you been 
troubled by the following symptoms?” was posed  for: 1) insomnia; 2) apathy; 3) 
anxiety; 4) depression; and 5) fatigue; respectively. The answering alternatives were 
four: 1) ’never’; 2) ’occasionally’; 3) ’sometimes’; and 4) ’frequently’; and points were 
given ranging from 1 to 4. All five questions were then summed to an index, maximum 
score 20. The index was divided into quartiles according to scoring frequencies, men 
and women combined. In analyses the two median quartiles were combined to one 
middle group, and the lowest scoring quartile was considered unexposed to 
psychological distress. “Low” was equivalent to 5-7.5 points, “middle” to 8-12 points, 
and “high” to 12.5-20 points. The Cronbach’s alpha (reliability of the index) was 
calculated to 0.80 for men and 0.81 for women. In addition, the single items of 
insomnia, apathy, anxiety, depression and fatigue were analysed separately. The 
response alternatives were then divided into three groups: ‘never’ (unexposed, 
low),’occasionally’ and ‘sometimes’ (middle) and ‘frequently’ (high). 
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3.4.4 Personality 
Personality traits were measured with the Hp5i (Health-relevant Personality 5-factor 
inventory), an instrument intended for large public health surveys and epidemiological 
studies81. 
 
The Hp5i describes five narrowly defined personality sub-traits; antagonism, 
impulsivity, hedonic capacity, negative affectivity and alexithymia. These are facets of 
the Five Factor Model personality factors; agreeableness, conscientiousness, 
extraversion, neuroticism and openness, respectively, and are thought to constitute 
aspects that are relevant for health, within those factors.  
 
 
Table 1 Item content for the five personality scales  
a Order of the question/item in the questionnaire 
      
Question/item     Noa 
      
      
Antagonism (as a facet of agreeableness)    
I’m good at making sarcastic comments   3 
If someone treats you badly, I basically feel you should treat them the same way back 8 
If someone criticises me, I’m not afraid of giving sharp and sarcastic answers 13 
Anyone who offends me or my family or friends can expect trouble 18 
  
Impulsivity (as a facet of conscientiousness)    
I have a tendency to act on the spur of the moment without really thinking ahead 4 
I often take on things too hastily 9 
I usually talk before I think 14 
I consider myself an impulsive person 19 
  
Hedonic capacity (as a facet of extraversion)    
My life is full of interesting things 1 
I find it easy to enjoy life 5 
I often feel happy and sort of elated when I’m about to meet a close friend 11 
I try to devote my time to things that make me feel involved 16 
  
Negative affectivity (as a facet of neuroticism)   
I often feel uneasy and uncomfortable for no apparent reason 2 
I’m easily pressured when told to speed up my work 7 
I often get so tense it wears me out 12 
An unexpected noise make me jump 17 
  
Alexithymia (as a facet of openness)    
I don’t usually analyse my feelings 6 
I think people often tend to exaggerate the importance of their emotions 10 
I often find it hard to understand what people mean when they talk about their feelings 15 
I prefer not to get involved in other people’s problems 20 
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The antagonism scale intends to capture to what extent an individual is being 
oppositional, sarcastic and argumentative (Table 1). The impulsivity scale estimates a 
person’s tendency to choose rapidly with little thought, act on the spur of the moment 
and not make plans. The hedonic capacity scale measures someone’s ability to enjoy 
life, be enthusiastic and engage in goal-directed behaviour. The scale of negative 
affectivity estimates to what extent a person is prone to be nervous, tensed and stressed. 
The alexithymia scale is supposed to capture individuals who tend to devaluate feelings 
and show a lack of interest in understanding and talking about emotions. The HP5i has 
been tested with satisfactory results for internal consistency and dimensionality81 and 
measurement invariance across sex and different age groups82.  
 
Each subscale had a four-point Likert response format including the answering 
alternatives “does not apply at all”, “does not apply very well”, “applies pretty much” 
and “applies completely”. The five subscale means for all participants were calculated 
and categorized into ”low”, constituting participants that had scored values <1 standard 
deviation (SD) of the mean of that particular subscale, ”middle” ±1 SD, and ”high >1 
SD. This is in line with subscales being approximately normally distributed, and that 
scores around the mean are considered “normal” according to construction of the scales 
and theory in personality research. Categorization was made separately in men and 
women, following the gender specific mean distributions. In the logistic regression 
models the middle group was used as the reference group and considered unexposed to 
either high or low values of that particular personality trait.  
 
 
3.5 DATA ANALYSIS 
The basic aim of the data analysis was to compare the prevalence of type 2 diabetes and 
pre-diabetes in exposed and unexposed subjects. We calculated prevalence odd ratios 
(OR), that may be interpreted as prevalence rate ratios since the prevalence of the 
outcome can be regarded as low. The ORs were estimated with 95% confidence 
intervals (CI) in multiple logistic regression analysis using SAS (SAS Institute, Cary, 
NC, USA). To take into account potential confounding we used two models, one 
adjusted for age, and one adjusted for potential confounders such as family history of 
diabetes, body mass index, smoking, physical activity, socio-economic position, and 
psychological distress. In study I, testing for potential confounding was made by 
including BMI, physical inactivity, and current smoking one by one in the logistic 
regression model. They were retained in the final model if they contributed at least a 
10% change in the age-adjusted crude estimate. In study I, biologic interaction between 
two risk factors was evaluated from the adjusted ORs, and analysed by testing whether 
the joint effect was greater than the sum of the independent effects of the single factors, 
i.e. departure from additivity37,38, by calculating the synergy index (SI)83. The SI is 
defined as equal to [OR11–OR00]/ [(OR01–OR00)+(OR10–OR00)], where the first index 
digit indicates the absence or presence of FHD and the second index digit indicates the 
other risk factor. Subjects not exposed to a family history of diabetes or the other risk 
factor served as the reference group: (OR00)=1. CIs (95%) for the SI were calculated 
according to the method of Hosmer and Lemeshow (1992). Comparison of continuous 
variables and categorical variables between two independent groups was assessed with 
the unpaired t-test and the χ² test, respectively. 
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4 RESULTS 
 
 
4.1 STUDY I: FAMILY HISTORY O F DIABETES AND LIFESTYLE 
In this cross-sectional study on baseline data, a family history of diabetes was 
associated with an increased risk of having abnormal glucose regulation. For pre-
diabetes the ORs were 1.6 (1.2-2.1) in men, and in women 1.5 (1.1-2.1), when 
controlled for age, BMI and physical activity (table 2). The corresponding estimates for 
type 2 diabetes were 3.1 (1.7-5.6) in men and 1.7 (1.0-3.0) in women. In order to 
evaluate if a family history of diabetes had a different influence on abnormal glucose 
regulation in men and women a synergy index assessing biological interaction between 
a family history of diabetes and sex was calculated. When using women without a 
family history of diabetes as the reference group, men with a family history of diabetes 
had higher ORs for all groups of abnormal glucose regulation, than women with a 
family history of diabetes, and men without a family history of diabetes. The synergy 
index indicated biological interaction between a family history of diabetes and sex, i.e. 
that the effects of a family history of diabetes and sex were not independent.  
 
Next, we estimated the combined effects of a family history of diabetes and obesity, 
physical inactivity, smoking, and low sense of coherence, respectively, and estimated 
synergy indexes. 
 
Obesity and family history of diabetes 
Men and women with both obesity and a family history of diabetes, had 6- and 11-fold 
elevated ORs for pre-diabetes and type 2 diabetes, respectively, compared to non-obese 
subjects without a family history of diabetes. The synergy index indicated independent 
effects of obesity and family history of diabetes in men, while in women a synergistic 
effect was demonstrated for pre-diabetes, SI 2.2 (1.0-4.5) and for pre-diabetes+type 2 
diabetes, SI 1.8 (1.0-3.2). Like in men, no biologic interaction was observed between 
obesity and a family history of diabetes for type 2 diabetes, SI 1.2 (0.5-2.8). Using 
waist circumference as a measure of abdominal obesity gave similar results. 
 
Physical activity and family history of diabetes 
Men that were exposed to both physical inactivity and a family history of diabetes, had 
an OR of 9.5 (4.1-22.1) for type 2 diabetes as compared to physically active men 
without a family history of diabetes. For men with pre-diabetes or women with pre-
diabetes or type 2 diabetes, the double exposure to physical inactivity and a family 
history of diabetes did not yield obviously higher ORs than being separately exposed to 
either of the factors. The synergy indexes suggested that physical inactivity and a 
family history of diabetes had independent effects.  
 
Smoking and family history of diabetes 
The combination of current smoking and a family history of diabetes resulted in an OR 
for type 2 diabetes of 4.4 (2.0-10.0) in men, while men with pre-diabetes and women 
with pre-diabetes or type 2 diabetes having both these risk factors had lower or 
comparable ORs to those exposed for only one factor. SI illustrated no departure from 
additivity. 
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Sense of coherence and family history of diabetes 
The combined exposure to low SOC and a family history of diabetes gave an 
approximately two-fold increase of ORs for pre-diabetes in men and women, and for 
type 2 diabetes in women, compared to the unexposed for both risk factors. In men, a 
four-fold increase was found for type 2 diabetes for those exposed to both risk factors 
individuals. However, no synergistic effects were indicated. 
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Table 2 Odds ratios (OR) for pre-diabetes, type 2 diabetes and the combined group of pre-diabetes plus type 2 diabetes associated with a family history 
of diabetes in men and women separately and in combinations of family history and sex  
Prediabetes is IFG, IGT, and IFG+IGT 
Biological synergy was analysed with the synergy index (SI) 
All analyses are adjusted for age (35-42, 43-50, 51-56), BMI (<25.0, 25.0-29.9, ≥30.0) and physical activity (sedentary, moderately active, regular 
exercise) 
 
 
      
 NGT  Pre-diabetes Type 2 diabetes Pre-diabetes + Type 2 diabetes 
      
 n  n OR 95% CI SI (95% CI) n OR 95% CI SI (95% CI) n OR 95% CI SI (95% CI) 
                 
Men                 
 Without FHD 1,409  80 1.0   14 1.0   94 1.0  
 With FHD 1,415  148 1.6 1.2-2.1  51 3.1 1.7-5.6  199 1.8 1.4-2.4  
           
Women           
 Without FHD 2,144  67 1.0   18 1.0   85 1.0   
 With FHD 2,388  139 1.5 1.1-2.1  44 1.7 1.0-3.0  183 1.6 1.2-2.0  
           
Combinations of          
men/women and FHD          
 Women without FHD 2,144  67 1.0   18 1.0   85 1.0   
 Men without FHD 1,409  80 1.8 1.3-2.5  14 1.4 0.7-2.8  94 1.7 1.2-2.3  
 Women with FHD 2,388  139 1.5 1.1-2.0  44 1.7 1.0-3.0  183 1.6 1.2-2.0  
 Men with FHD 1,415  148 2.9 2.1-3.9 1.4 (0.9-2.4) 51 4.1 2.3-7.1 2.8 (0.9-9.0) 199 3.1 2.4-4.1 1.7 (1.0-2.8) 
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4.2 STUDY II: PSYCHOLOGICAL DISTRESS  
In this prospective study, a larger proportion of women (28,5%) had a high baseline 
psychological distress score, compared with men (13.0%). Men in the highest quartile 
of psychological distress were more than twice as likely to develop type 2 diabetes as 
men scoring in the lowest group, when adjusted for age, BMI, FHD, smoking physical 
activity and SEP (Table 3). Correspondingly, the risk for pre-diabetes was twice as high 
for high scorers as for low scorers of psychological distress among men. In women, no 
increased risk of type 2 diabetes associated with psychological distress was found. 
However, psychological distress was associated with pre-diabetes in the middle-scoring 
group in women, OR 1.8 (1.1-3.0) compared to the low-scoring group when adjusted 
for all named potential confounders.  
 
When analysing the five questions separately, each of them yielded about equal ORs. In 
men, the ORs for fatigue, insomnia, anxiety and apathy in association with pre-diabetes 
plus type 2 diabetes (combined group to obtain better power) ranged from 1.8 to 2.8 
when adjusted for all potential confounders, for the group reporting frequent problems 
(highest group). For depression, only the association for the middle scoring group in 
men was significant, OR 1.3 (1.0-1.7) when fully adjusted. In women, none of the 
single items was associated to abnormal glucose regulation. 
 
 
4.3 STUDY III: PERSONALITY  
In this cross-sectional study on follow-up data, men with low scores on the 
antagonism scale had a 70% reduced risk of having abnormal glucose regulation, 
compared to men with middle scores: age-adjusted OR 0.3 (CI 0.2-0.6) which 
was not altered when also BMI, FHD, smoking, physical activity, SEP and 
psychological distress were included in the model (table 4). In women, low 
antagonism was not associated with abnormal glucose regulation. High scores on 
the antagonism scale were not associated with abnormal glucose regulation in 
neither men nor women. Analyses of the hedonic capacity scale showed a 50 and 
40% decreased risk of having abnormal glucose regulation for men and women, 
respectively: age-adjusted ORs 0.5 (0.3-0.9) and 0.6 (0.4-1.0), which were 
unchanged after control for all the potential confounders. For the group reporting 
low values on hedonic capacity there were no associations in men, although in 
women an increased risk was observed, age-adjusted OR 1.7 (1.1-2.6) that was 
no longer significant when adjusted for all the potential confounders, OR 1.4 
(0.9-2.4). However, the association for hedonic capacity in women indicated a 
dose-response pattern. Alexithymia, impulsivity and negative affectivity were not 
associated with abnormal glucose regulation in either men or women, although 
high negative affectivity conferred an age-adjusted OR of 1.3 (1.0-1.8) in men, 
which became non-significant when the potential confounders were entered in the 
model, OR 1.3 (0.9-1.8). Likewise, for low impulsivity in men, the age-adjusted 
OR was 0.7 (0.4-1.0), which became non-significant when multi-adjusted, OR 
0.7 (0.5-1.1).
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Table 3 Odds ratios (OR) and 95% confidence intervals (CI) for the association between baseline psychological distress and pre-diabetes and type 2 
diabetes at follow-up  
a Data adjusted for age (35-42, 43-49 and 50-56 years) 
b Data adjusted for age (35-42, 43-49 and 50-56 years), body mass index (≤24.9, 25–29.9 and ≥30.0 kg/m²), family history of diabetes (no/yes), smoking 
(never, former and current), physical activity (regular, moderate and sedentary) and socio-economic position (high, middle, low and self-employed)  
Psychological distress score groups represent quartiles, men and women combined, where the middle group refers to the two median quartiles (those 
between the lower and upper quartiles) 
         
     Pre-diabetes+   Pre-diabetes+ 
Index of NGT  Pre-diabetesa Type 2 diabetesa type 2 diabetesa  Pre-diabetesb Type 2 diabetesb type 2 diabetesb 
psychological          
distress n  n OR 95% CI n OR 95% CI OR 95% CI  OR 95% CI OR 95% CI OR 95% CI 
                  
Men                  
 Low 626  75 1.0  26 1.0  1.0 1.0 1.0  1.0  
 Middle 951  121 1.1 (0.8−1.5) 51 1.3 (0.8−2.2) 1.2 (0.9-1.5) 1.1 (0.8−1.4) 1.2 (0.7−2.0) 1.1 (0.8-1.4) 
 High 202  49 2.1 (1.4−3.1) 26 3.3 (1.8−5.7) 2.4 (1.7-3.4) 1.9 (1.2−2.8) 2.2 (1.2−4.1) 2.0 (1.4-2.8) 
Women          
 Low 431  18 1.0  12 1.0  1.0 1.0 1.0  1.0  
 Middle 1612  113 1.7 (1.0−2.8) 29 0.7 (0.3−1.3) 1.3 (0.8-1.9) 1.8 (1.1−3.0) 0.7 (0.3−1.4) 1.4 (0.9-2.1) 
 High 823  46 1.3 (0.8−2.3) 16 0.7 (0.3−1.5) 1.1 (0.7-1.7) 1.2 (0.7−2.1) 0.5 (0.2−1.2) 0.9 (0.6-1.5) 
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Table 4  Odds ratios (OR) and 95% confidence intervals (CI) for the association between personality traits and pre-diabetes + type 2 diabetes in 2152 men and 3143 
women in Stockholm Diabetes Prevention Programme 
  Men         Women       
  NGT  Prediabetes+T2Dª  Prediabetes+T2Db  NGT  Prediabetes+T2Dª  Prediabetes+T2Db 
  n  n OR  (95% CI)  OR  (95% CI)  n  n OR  (95% CI)  OR  (95% CI) 
 Antagonism                   
 Low 166  10 0.3  (0.2-0.6)  0.3  (0.2-0.6)  289  23 1.1  (0.7-1.7)  1.2  (0.7-1.9) 
 Middle 1349  254 1.0 REF  1.0 REF  2225  158 1.0 REF  1.0 REF 
 High 321  52 0.9  (0.6-1.2)  0.8  (0.6-1.1)  416  32 1.1  (0.7-1.6)  1.0  (0.6-1.5) 
 Impulsivity             
 Low 266  32 0.7  (0.4-1.0)  0.7  (0.5-1.1)  393  36 1.3  (0.9-1.9)  1.4  (0.9-2.0) 
 Middle 1353  243 1.0 REF  1.0 REF  2194  152 1.0 REF  1.0 REF 
 High 217  41 1.0  (0.7-1.5)  0.8  (0.6-1.2)  343  25 1.1  (0.7-1.7)  1.0  (0.6-1.6) 
 Hedonic capacity                  
 Low 185  33 1.0  (0.7-1.5)  0.8  (0.5-1.3)  200  24 1.7  (1.1-2.6)  1.4  (0.9-2.4) 
 Middle 1475  266 1.0 REF  1.0 REF  2236  169 1.0 REF  1.0 REF 
 High 176  17 0.5  (0.3-0.9)  0.5  (0.3-0.9)  494  20 0.6  (0.4-1.0)  0.6  (0.4-1.0) 
 Negative affectivity             
 Low 141  19 0.8  (0.5-1.3)  0.8  (0.5-1.4)  365  25 0.9  (0.6-1.4)  0.9  (0.6-1.5) 
 Middle 1448  242 1.0 REF  1.0 REF  2115  155 1.0 REF  1.0 REF 
 High 247  55 1.3  (1.0-1.8)  1.3  (0.9-1.8)  450  33 1.0  (0.7-1.4)  0.8  (0.5-1.2) 
 Alexithymia             
 Low 187  26 0.8  (0.5-1.2)  0.9  (0.6-1.4)  479  28 0.9  (0.6-1.3)  1.0  (0.6-1.5) 
 Middle 1435  251 1.0 REF  1.0 REF  2262  166 1.0 REF  1.0 REF 
 High 214  39 1.0  (0.7-1.4)  0.9  (0.6-1.4)  189  19 1.3  (0.8-2.1)  1.1  (0.7-2.0) 
ª Data adjusted for age (43-50, 51-55, 56-60 and 61-66 years) 
b Data adjusted for age (43-50, 51-55, 56-60 and 61-66 years), body mass index (≤24.9, 25.0–29.9 and ≥30.0 kg/m²) family history of diabetes (no, yes, insufficient), 
smoking (never, former and current), physical activity (regular, moderate and sedentary), SEP (high, middle, low and self-employed/farmers) and psychological 
distress (low, middle and high). Personality traits score groups represent distribution of means for each trait: <1 SD (low) ±1 SD (middle) and >1 SD (high).  
The middle group is treated as the reference group for all subscales (OR 1.0)  
Analyses include participants with information on all potential confounders 
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4.4 STUDY IV: INFLUENCE OF NON-RESPONSE  
In this prospective study, the absolute risks of drug-treated diabetes were similar 
in responders and non-responders to the initial screening questionnaire, 8.7 and 
7.7% in men, and 4.0 and 3.8% in women (table 5). At the baseline step, the 
absolute risks in participants and non-participants were 8.5 and 7.2% 
respectively, in men, and 3.8 and 3.2% in women (table 6). The relative 
comparisons did reveal no increased risks for drug-treated diabetes for non-
responders/non-participants compared to responders/participants at neither the 
screening- nor the baseline step. At the follow-up step, the absolute risks for 
participants and non-participants were 4.4 and 6.2% respectively, in men, and 1.6 
and 2.6% in women (table 7). The relative measures illustrated increased risks for 
drug-treated diabetes in follow-up non-participants compared to participants. 
 
The proportion of non-responders/non-participants at the screening and baseline 
steps that later was classified with drug-treated diabetes was about the same in 
men and women. However, at follow-up, this proportion was higher among 
women than among men: 39.8% (33/83) of women with drug-treated diabetes 
and 25.2% (32/127) of men, did not attend the SDPP follow-up. 
 
Subsequently, baseline exposures were studied in association with either type 2 
diabetes measured at the SDPP follow-up, or drug-treated diabetes, the results 
illustrated that previous estimates for FHD, smoking, physical activity, SEP and 
psychological distress measured in the SDPP did not seem to be overestimated. 
However, in women, selective non-participation in the SDPP follow-up study 
was indicated for BMI, whilst the OR for drug-treated diabetes in the obese group 
(BMI ≥ 30) was lower in non-participants, age-adjusted OR 2.8 (1.2-6.9) than in 
participants OR 13.7 (6.2-30.1). The pattern for men was the opposite, the OR for 
drug-treated diabetes in obese men was somewhat higher in non-participants, 
age-adjusted OR 12.0 (3.6-39.3) than among participants OR 10.7 (5.6-20.3), 
although these estimates were not statistically different from each other.  
 
In addition, the prospective analyses in the present study confirmed the results 
from study I in that family history of diabetes is an important risk factor in both 
men and women. Regarding psychological distress the register data mirrored the 
results from study II, in that women did not have an increased risk for drug-
treated diabetes in neither the middle nor high psychological distress groups, and 
for men as the risk was increased for high psychological distress. The elevated 
risk for pre-diabetes in men and women reported in study II, was not possible to 
evaluate with the Swedish Prescribed Drug Register 
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Table 5 Absolute risks (%) and ORs for drug-treated diabetes in responders and non-responders to the postal screening questionnaire (Step 1). 
Absolute risks are stratified in age-groups  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ªORs adjusted for attained age 2005 (start of the Swedish Prescribed Drug Register) (44-51, 52-59 and 60-67) 
bORs adjusted for attained age 2005 (44-51, 52-59 and 60-67) and socioeconomic position (high, middle, low and self-employed) 
   
  Filled at least one prescription of anti-diabetic drugs during the period between July 1, 2005 and November 30, 2008 
              
              
Men (age)  48-51 52-59 60-67 All     
  (n=2,045) (n=4,931) (n=5,021) (n=11,997)     
  n (%) n (%) n (%) n (%) ORª (95% CI) ORb (95% CI) 
              
 Responders  73 (4.8) 304 (8.0) 448 (10.7) 825 (8.7) 1.0    1.0   
 Non-responders  20 (3.8) 79 (7.1) 92 (11.1) 191 (7.7) 0.9 (0.8-1.1) 0.9 (0.7-1.1) 
 All  93 (4.6) 383 (7.8) 540 (10.8) 1,016 (8.5)         
                  
Women (age)  44-51 52-59 60-63 All     
  (n=7,208) (n=7,287) (n=3,991) (n=18,486)         
  n (%) n (%) n (%) n (%) ORª (95% CI) ORb (95% CI) 
              
 Responders  140 (2.4) 270 (4.3) 212 (6.0) 622 (4.0) 1.0    1.0   
 Non-responders  32 (2.3) 48 (4.6) 28 (6.7) 108 (3.8) 1.1 (0.9-1.3) 1.0 (0.8-1.2) 
 All  172 (2.4) 318 (4.4) 240 (6.0) 730 (3.9)         
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Table 6 Absolute risks (%) and ORs for drug-treated diabetes in baseline participants and non-participants (among 11,125 individuals who where invited 
to the SDPP baseline study) (Step 2). Absolute risks are stratified for information on FHD or gestational diabetes in the postal screening questionnaire  
ªORs adjusted for age attained age 2005 (start of the Swedish Prescribed Drug Register) (44-51, 52-59 and 60-67) 
bORs adjusted for attained age 2005 (44-51, 52-59 and 60-67), family history of diabetes (no/yes), and socioeconomic position (high, middle, low and 
self-employed) 
   
  Filled at least one prescription of anti-diabetic drugs during the period between July 1, 2005 and November 30, 2008 
              
                
Men  FHD+ FHD-   All       
  (n=1,945) (n=2,264)   (n=4,209)       
  n (%) n (%)   n (%) ORª (95% CI) ORb (95% CI) 
              
 Baseline participants 186 (12.2) 66 (4.6)   252 (8.5) 1.0   1.0  
 Baseline non-participants 49 (11.6) 40 (4.9)   89 (7.2) 0.9 (0.7-1.1) 1.0 (0.8-1.3) 
 All  235 (12.1) 106 (4.7)   341 (8.1)       
                
                
Women  FHD+ FHD- Gestational diabetes All     
  (n=3,082) (n=3,433) (n=401) (n=6,916)     
  n (%) n (%) n (%) n (%) ORª (95% CI) ORb (95% CI) 
              
 Baseline participants 120 (5.0) 40 (1.9) 17 (9.1) 177 (3.8) 1.0   1.0  
 Baseline non-participants 35 (5.0) 23 (1.8) 14 (6.5) 72 (3.2) 0.9 (0.7-1.2) 1.0 (0.7-1.3) 
 All  155 (5.0) 63 (1.8) 31 (7.7) 249 (3.6)       
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Table 7 Absolute risks (%) and ORs for drug-treated diabetes in follow-up participants and non-participants, among 7,136 baseline participants 
classified with normal glucose tolerance (Step 3). Absolute risks are stratified for baseline FHD  
ªORs adjusted for age at baseline (35-42, 43-49 and 50-56) 
bORs adjusted for age at baseline (35-42, 43-49 and 50-56), family history of diabetes (no/yes), body mass index (≤24.9, 25.0-29.9 and ≥30.0), smoking 
(never, former and current), physical activity (regular, moderate and sedentary), socio-economic position (high, middle, low and self-employed) and 
psychological distress (low, middle and high).  
   
  Filled at least one prescription of anti-diabetic drugs during the period between July 1, 2005  
and November 30, 2008 
              
              
Men  FHD+ FHD- All       
  n=1,356 n=1,346 n=2,702     
  n (%) n (%) n (%) ORª (95% CI) ORb (95% CI) 
              
Follow-up participants  76 (6.8) 19 (1.8) 95 (4.4) 1.0   1.0   
Follow-up non-participants 20 (8.2) 12 (4.4) 32 (6.2) 1.4 (1.0-2.2)  1.4 (0.9-2.3) 
All  96 (7.1) 31 (2.3) 127 (4.7)       
              
Women  FHD+ FHD- All       
  n=2,093 n=2,341 n=4,434       
  n (%) n (%) n (%) ORª (95% CI)  ORb (95% CI) 
Follow-up participants  41 (2.5) 9 (0.6) 50 (1.6) 1.0   1.0   
Follow-up non-participants  24 (3.6) 9 (1.5) 33 (2.6) 1.8 (1.1-2.8)  1.5 (0.9-2.4) 
All  65 (2.8) 18 (0.9) 83 (1.9)       
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5 DISCUSSION 
 
 
5.1 THE FINDINGS 
 
5.1.1 Family history and lifestyle 
Family history of diabetes was associated with abnormal glucose regulation in men 
and in women. Biological synergy between a family history of diabetes and sex 
was demonstrated, and indicated that a family history of diabetes might have a 
greater influence on the association to type 2 diabetes in men compared to women. 
The familial component is well known in the aetiology of type 2 diabetes and is 
important for both men and women22-24,84-86 .  
 
The question may be raised if the observation in the present study of a different 
influence of family history of diabetes in men and women, could be due to 
misclassification of family history of diabetes. There might be a difference in men 
and women with regard to knowledge about diabetes in relatives. For example,  
there could be under-reporting in men, so that among men who claimed they did 
not have a family history of diabetes there were men that actually had a family 
history of diabetes. Even if this was not the case in women, and they instead had 
knowledge of all relatives with diabetes, there is no reason to believe that among 
men or women, those with disease (cases) and those without (the controls) differed 
with regard to knowledge about diabetes in their family. The participants did not 
know if they were going to be classified with abnormal glucose regulation or not. 
An overestimation in for instance men would appear only if male cases did have a 
better knowledge about relatives with diabetes compared with male controls. In this 
context it may be mentioned that the original prevalence of a family history of 
diabetes at the SDPP screening phase was fairly similar in men and in women, 
approximately 21.6% in men and 24.5% in women. The slightly higher occurrence 
in women might be attributed to that the studied women were somewhat older 
compared to men, and thereby had more relatives with diabetes, or that women 
may have more knowledge about diabetes in their family.  
 
When the combined effects of a family history of diabetes and other risk factors; 
BMI, waist, physical activity, smoking and sense of coherence, respectively, were 
studied, an exposure to two risk factors conferred higher ORs than being exposed 
to only one risk factor (with one or two exceptions). However, analysis of biologic 
interaction according to the synergy index indicated no departure from additivity, 
i.e. no further effect due to the combination of two risk factors, except for the joint 
effect of a family history of diabetes and obesity in women having pre-diabetes. In 
men, no synergistic effect between a family history of diabetes and obesity was 
demonstrated, either for pre-diabetes or type 2 diabetes separately, or for the 
combined outcome. Thus, it is possible that the interaction between a family history 
of diabetes and obesity varies between men and women as well as through the 
progression of milder forms of abnormal glucose regulation to manifest diabetes.  
 
Biologic interaction between a family history of diabetes and obesity has been 
reported in women with self-reported type 2 diabetes in a large cohort of 32,662 
women aged 40-70 years36. Also, interaction (calculated with a product term in a 
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linear regression analysis) has been reported in relation to fasting plasma glucose 
35. In the latter study, interaction was found only in women when BMI was used as 
the measure of body fatness, whereas, in contrast to our study, an interaction in 
both men and women was found when waist circumference was used. In a study 
published in 2010 of 2,081 adults 18-79 years old, biologic interaction between a 
family history of diabetes and overweight/obesity measured with the synergy index 
was demonstrated in both men and women with self-reported diabetes87.  
 
It is important to note that, like type 2 diabetes, obesity has both genetic and 
lifestyle-related components22,30,84 and aggregates in families88. However, a recent 
study reported that BMI and type 2 diabetes may actually share only little genetic 
variance89. Our study can not separate the effects of genetic and lifestyle-related 
exposures being a part of a family history of diabetes. Family history of diabetes 
most likely reflects, in addition to the genetic influence also family-shared 
conditions, such as socioeconomic group, family values, educational levels and 
eating habits90.  
 
The published paper did not include the crude estimates, i.e. adjusted for only age. 
These results were similar to the results from the published adjusted analysis. However, 
as expected most point estimates became slightly higher when BMI and physical 
activity were excluded from the model. For instance, in both men and women, the 
association between FHD and abnormal glucose regulation became stronger. 
Additional biological synergy between risk factors was not observed in the crude 
models.  
 
 
5.1.2 Psychological distress 
Self-reported psychological distress, including symptoms of anxiety, apathy, 
depression, fatigue and insomnia was associated with later development of pre-
diabetes and type 2 diabetes in Swedish middle-aged men. In women, associations 
between psychological distress and onset of type 2 diabetes was not present, 
although an association was observed for pre-diabetes. These results are in line 
with previous longitudinal studies demonstrating an influence of depression on the 
development of type 2 diabetes61,91. Since our study was published, the body of 
literature on the issue has somewhat expanded. Studies may include also data on 
antidepressant use which has been suggested to be involved in the association 
between depression and type 2 diabetes. However, when anti-depressant drugs are 
adjusted for, the association between depression and type 2 diabetes seems to 
persist92,93. Another study on 161,808 postmenopausal women found slightly 
increased independent risks of incident diabetes with elevated depressive symptoms 
or antidepressant use94. The observed association of antidepressant use and type 2 
diabetes has been suggested to be due to confounding by indication (the true 
association may not exist between the medication and the outcome, but between the 
indication for the outcome, i.e. depression, and the outcome95. Nevertheless, the 
relation between depression and diabetes is probably complex, and potentially 
bidirectional, i.e. type 2 diabetes may also lead to depression96-97 .  
 
Another issue is the possible role of sleep disturbances in the prospective relation 
between depression and type 2 diabetes. Sleep problems and depression are related 
to each other, and also to cardiometabolic diseases (cardiovascular disease, 
diabetes, and the metabolic syndrome)98. Consequently, an association between 
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depression and cardiometabolic diseases could partly be due to effects of different 
types of sleep problems. There are insufficient data to conclude whether depression 
and sleep problems have independent effects on cardiometabolic outcomes 
according to a recent review98. In a Swedish study of 2,663 subjects 45-65 years 
old, the age-adjusted RR of depression associated with type 2 diabetes in men 
disappeared after control for other confounders, including difficulties initiating 
sleep, and difficulties maintaining sleep58. In our study, when evaluating the 
psychological distress index, insomnia was included among the other symptoms.  
 
Our results indicated an increased risk for type 2 diabetes associated with 
psychological distress in men, however in women only for pre-diabetes. 
Associations between depression and type 2 diabetes have been reported in studies 
including only women99,100. Another study in 37,291 subjects in Norway101, 
demonstrated an association between anxiety and depression and type 2 diabetes 
for both men and women. Also, lack of associations has been reported for both men 
and women52,58. Some studies that demonstrated an association between depressive 
symptoms and type 2 diabetes did not separate the analyses for men and 
women56,102,103. The type of measurement of depression and diabetes status did vary 
across the studies, which also applies to the reported meta-analyses.  
 
In this study, we referred to our exposure as symptoms of psychological distress 
since it was not a validated instrument for diagnosing clinical depression. An 
instrument diagnosing a narrow span of clinical depression may result in a lower 
prevalence of depression than questionnaires evaluating self-reported symptoms of 
depression or distress. An important point is that mental ill-health in the population 
is hard to define and there is no perfect method for this104. One meta-analysis 
evaluating depression as a risk factor for cardiovascular disease resulted in stronger 
effects for clinical depression, RR 2.69 (1.63-4.43) compared to depressive mood, 
RR 1.49 (1.16-1.92)105. Nevertheless, a single simple question about feelings of 
nervousness, uneasiness, and anxiety may strongly predict suicide attempts and 
psychiatric disease 5-10 years later106. 
 
Also when the symptoms were analysed as single entities in association with 
abnormal glucose regulation (pre-diabetes+type 2 diabetes), symptoms of 
insomnia, apathy, anxiety and fatigue to a similar extent influenced the risk in men. 
However, the association in women disappeared. This may be due to that the 
outcome groups had been combined to one, and also, that the exposure group 
categories (“low”, “middle” and “high”) were different when analysing the 
questions as single entities (compared to the index). It may be mentioned again that 
the scale of measurement had flaws, including that the two middle answering 
alternatives looked fairly alike. However, these two answering options were 
combined to one (i.e. “middle”) in the analyses of the single questions. Also, even 
though the exposure was somewhat misclassified, it should not differ between 
those with pre-diabetes or type 2 diabetes, and those with normal glucose tolerance 
since these (cases and controls) were unaware of their disease status at baseline 
when the exposure was measured.  
 
In our study women reported symptoms of psychological distress to a greater extent 
than the men did. In recent studies in Sweden it has been documented that women 
over time self-report more anxiety107, mental ill-health (GHQ12)108 and sleeping 
problems or persistent fatigue104 than men do, and also use both more in- and out-
patient mental health care107. It is reasonable to assume that the difference in 
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symptoms reporting between men and women in our study represents an actual 
difference in psychological distress, but it could also reflect for instance that the 
content of the questions have a different meaning for men and women, or, a 
difference in for instance what may be expected from gender roles to report109 . 
Another possibility is that men and women use different coping strategies to handle 
psychological distress and that this influences the risk for type 2 diabetes109 . It 
could be speculated that men under-report feelings of distress, and when they 
finally admit them they have become severe, and are affecting the neuroendocrine 
stress systems. Consequently, we could speculate that the influence of 
psychological distress on type 2 diabetes was diluted in women in our study. On the 
other hand, an association was noted in women for pre-diabetes in the middle index 
group. It is possible that the results for women would be different if psychological 
distress/depression was measured with other instruments99-101 .  
 
 
5.1.3 Personality 
In this cross-sectional study, a reduced risk of previously unknown pre-diabetes or 
type 2 diabetes was observed for men with low scores on the antagonism scale. 
This is indirect in accordance with a few previous studies reporting an association 
between hostility or anger and blood glucose and insulin levels67-69. Also, one 
prospective study of 11,615 middle-aged men and women has reported a slight 
overrisk for type 2 diabetes associated with anger temperament after control for 
potential confounders including BMI and waist-to-hip ratio71. Studies on the role of 
hostility or anger in the aetiology of cardiovascular disease are more frequent and 
suggest an association72,73, although one meta-analysis indicates that the effect is 
not that prominent110. The results in our study might reflect that individuals scoring 
low on a hostility scale express a lower neuoroendocrine stress response111,112  
which may be associated with a lower risk of developing type 2 diabetes113. 
 
A decreased risk for having abnormal glucose regulation was demonstrated in men 
and women with high scores on the hedonic capacity scale. Hedonic capacity 
includes “positive emotionality”, and the ability to enjoy and be enthusiastic about 
everyday life81. The literature on hedonic capacity in relation to health outcomes is 
limited114. In one study of 10,308 civil servants in London, a measure of “positive 
affect” was not associated with coronary heart disease75. In the present study, also 
low hedonic capacity in women was associated with abnormal glucose regulation, 
demonstrating an increased risk, although when the potential confounders were 
controlled for the association became non-significant. Scores on the lower range of 
the hedonic capacity scale intend to capture low mood, disengagement and feelings 
of helplessness. An increased risk for low hedonic capacity may correspond with 
that also depression91 and psychological distress115, has been shown to predict type 
2 diabetes. However, the decreased risk in both men and women for having 
abnormal glucose regulation associated with high scores on hedonic capacity were 
more persistent after adjustment for confounders and could, like proposed for 
antagonism, operate through neuroendocrine stress systems, implying that 
individuals high on hedonic capacity, may express a lower stress response. 
 
For the three other personality scales, there were no significant associations to 
abnormal glucose regulation in either men or women. The slightly reduced risk for 
low impulsivity in men, and over-risk for high negative affectivity in men, became 
non-significant after adjustment for BMI, FHD, smoking, physical activity, SEP 
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and psychological distress. It is however noteworthy, that negative affectivity, 
referring to an individual’s susceptibility to negative emotions expressed as nervous 
tension and stress, most probably share features with, for example, the single 
question of anxiety that was prospectively associated with abnormal glucose 
regulation in our previous study115 . The results from the present study refer to a 
narrowly defined personality trait and may be put in contrast to a single unvalidated 
question on symptoms on anxiety115 . Different measures or concepts of 
personality, emotional stress or depressive symptoms may overlap in what they 
capture. 
 
The selection of comparison group might influence the results. We used exposure 
scores around the mean as the reference. This is in accordance with the subscales 
being approximately normally distributed, and that scores around the mean are 
considered “normal” according to construction of the scales and theory in 
personality research. If you contrast the groups with extreme scores to each other, 
you may end up with stronger associations. Also, to estimate “overrisks” or 
“underrisks” may be a matter of preference and is due to which exposure group is 
labelled as reference, i.e. having OR 1.0. If low antagonism is the reference, high 
antagonism may confer an overrisk, instead of low antagonism being “protective”. 
 
The point estimates were fairly robust after entering known confounding factors 
into the model which may be a sign of that they are distinct entities. Although BMI, 
that is a strong risk factor for type 2 diabetes was included among the potential 
confounders, the association between personality traits and abnormal glucose 
regulation were not changed.  
 
Personality trait theory has a long tradition since the first documented person to suggest 
trait theory was Hippocrates (460-377 BC), describing humans having four basic fluids 
(or humors); yellow bile, blood, phlegm and black bile. Although a lot has happened to 
trait theory since then, traits are often referred to as ”dispositions”, capturing the idea 
that a person is predisposed to act in a certain way116. However, it has recently been 
emphasized that trait terms implicitly refer to behaviours in a type of social context117 . 
One old critique of trait theory is its conception of humans being pre-disposed to act in 
certain ways. Our personalities are too dynamic to say that we have a high level of 
some specific trait. Individuals do not always act in the same way, it depends on the 
situation118. Another criticism has been that if trait theory offers no real guidance in the 
development of these traits, there is no strategy for helping someone to change. 
However, recent research stresses that personality does change, predominately in young 
adulthood (age 20-40)119. 
 
 
5.1.4 Non-response 
The main results of this study indicated the absence of non-response bias at the 
screening- and baseline steps of the SDPP study, since the absolute risks for non-
responders/non-participants were equivalent to those for responders/participants, 
and accordingly, the ORs for non-responders/non-participants were not increased. 
In contrast, at the follow-up step, the risk for drug-treated diabetes was increased in 
non-participants compared to participants, suggesting that the sample had been 
subjected to some kind of selection towards healthier subjects.  
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Thereafter, we analysed the result in more detail for several of the type 2 diabetes 
risk factors measured at the baseline study. This evaluation suggested no false risk 
estimates for either men or women for FHD, smoking, physical activity, socio-
economic position or psychological distress. For BMI though, the ORs illustrated 
separate patterns for men and women, and participation seemed to some extent to 
be selective in women, i.e. related to disease status within the BMI categories. This 
could lead to an overestimation of risk estimates associated with a high BMI. 
 
The results also suggested that a higher proportion of all drug-treated diabetes cases 
among women than among men were non-participants, which probably means that 
a higher proportion of type 2 diabetes cases in women were not examined in the 
SDPP follow-up. If so, this may mirror the lower participation rate at the follow-up 
in women, 70% compared to men, 79%. It is also possible, that women who knew 
they had diabetes, i.e. had been diagnosed during the follow-up period, to greater 
extent declined to participate, compared to men. In addition, in women, BMI ≥ 30, 
low physical activity, low SEP and high psychological distress were more prevalent 
at baseline among follow-up non-participants than among participants (Eriksson et 
al). Current smoking was more prevalent in non-participants in both men and 
women. At the same time, despite adjustment for these potential confounders, the 
elevated risk for drug-treated diabetes in non-participants at follow-up persisted, in 
both men and women. This may be due to other unmeasured factors which increase 
the risk for diabetes in our non-participants.  
 
In conclusion, this evaluation with the Swedish Prescribed Drug Register supports 
the hypothesis that non-response bias is not a problem in the SDPP study at 
screening and baseline steps. This suggests that diabetes prevalence and risks may 
be estimated from a population-based cohort study on type 2 diabetes with high 
participation rate, such as the SDPP. However, a potential problem may exist in the 
follow-up step, because after having performed several steps the sample may have 
been subjected to selection bias. Hence, follow-up data should be interpreted with 
some caution. The overall lower response rate at follow-up in women, and 
presumably higher proportion of missed cases points to the importance of 
motivating women to participate in a diabetes health exam. 
 
 
5.2 METHODOLOGY 
 
5.2.1 Study design 
SDPP is a population-based cohort study. The second and fourth papers in this 
thesis were incidence studies taking advantage of the prospective design which 
render possible causal interpretation. The first and third studies were cross-
sectional studies where the exposure and disease are measured at the same point in 
time. This implies that any temporal relationship is impossible to assess. However, 
all prevalent cases of type 2 diabetes were excluded prior to the baseline study. 
This makes it less likely that changes in habits or symptoms (smoking, physical 
activity, psychological distress), or recall bias of exposure levels, occurred in this 
group as a result of knowledge of disease. For the same reason, only the subjects 
that were classified with normal glucose tolerance at baseline were included in the 
prospective analyses in the second and fourth papers. (The individuals with pre-
stages were informed to contact their primary health care centre for help with life 
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style changes, and individuals diagnosed with type 2 diabetes were referred to a 
physician for treatment). 
 
 
5.2.2 Misclassification of disease 
Glucose tolerance in the SDPP was measured by screening with OGTT. This is an 
advantage compared to self-report, making it possible also to include previously 
undiagnosed cases of type 2 diabetes and pre-diabetes which otherwise will be 
missed. Such under-diagnosing can be substantial, for two diagnosed cases there 
will be one undiagnosed11 . Since the individuals with known type 2 diabetes were 
excluded prior to baseline and follow-up, it is possible that we have been studying 
less intense, essentially symptoms-free forms of type 2 diabetes. However, there is 
no evidence that the aetiology of milder type 2 diabetes would differ from more 
severe cases. On the other hand, the exclusion of the prevalent cases may entail that 
individuals particularly vulnerable to the studied exposures have been sorted out 
possibly leading to an underestimation of the studied associations. 
 
In the fourth study, the non-response analysis, type 2 diabetes was measured as 
filled prescriptions of anti-diabetic drugs recorded in the Swedish Prescribed Drug 
Register. The advantage of this measure was the possibility to estimate the disease 
risk for the entire original SDPP cohort, including the non-participants. The 
complete accuracy of anti-diabetic drugs as a measure of type 2 diabetes can be 
questioned. There will be under-diagnosing of cases treated with diet only, about 
25%, and the register also lacks information of unknown cases of type 2 diabetes. 
However, the participants in SDPP are already screened for unknown type 2 
diabetes, so under-diagnosing should not be considerable in this group. Moreover, 
as long as misclassification is not related to exposure, which it should not be in this 
case, a crude method for identification of cases will not result in spurious 
associations. Even though the diabetes cases in the SDPP cohort drawn from the 
Swedish Prescribed Drug Register were treated with anti-diabetic drugs including 
insulin, they were not likely to have type 1 diabetes since all individuals with 
diabetes were excluded prior to the SDPP baseline study. In addition, it is 
reasonable to assume that only few of those who developed diabetes during the 
follow-up period have type 1 diabetes, considering their age (above 35 years at 
baseline). We can not rule out that some of our cases have latent autoimmune 
diabetes in the adult (LADA) since anti-GAD were not analysed. LADA amounts 
to 5-10% of all diabetes and a criteria is a disease debut above 30-35 years of age4 . 
Although characterised by autoimmunity to betacells like type 1 diabetes, it has 
been shown that LADA share risk factors such as FHD120 , overweight, low 
physical activity and increasing age121 with type 2 diabetes.  
 
 
5.2.3 Misclassification of exposure 
Most lifestyle exposures were self-reported and evaluated from questionnaires, and 
this may introduce bias, due to misclassification. The personality instrument has 
been evaluated with regard to reliability and validity with satisfactory results, partly 
on the present data cohort81,82 . Also, measurement of personality ought not to 
introduce recall bias, since it is intended to capture a more regular personal pattern 
of behaviour or attitudes. The psychological distress index was not a validated 
instrument, although showed adequate reliability according to the Cronbach’s 
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alpha. We also analysed the separate questions included in the index, for 
clarification. The different results in men and women is perhaps most striking, and 
since validation is lacking it can’t be excluded that the instrument measures 
different things in men and women, although the level of symptoms reporting is in 
line what have previously been found. However, since men and women were 
compared within gender, it is not likely that in between gender differences explain 
the association observed in men or women. The scale of SOC was a short version 
reported to be adequately valid80. However, as already stated, an obvious advantage 
was that the participants were not aware of their glucose status at the baseline 
health examination when answering the questionnaire, thereby making differential 
misclassification (in the group with disease and the group without disease) with 
regard to psychological distress, personality, smoking, physical activity, and SOC 
less likely.  
 
 
5.2.4 Selection 
The study sample in the SDPP was restricted to Swedish-born individuals, and half 
of the participants had a family history of diabetes and half had not. All individuals 
that had an unclear or insufficient family history of diabetes were excluded. The 
reason for applying the inclusion and exclusion criteria was to enrich the study 
population with regard to family history of diabetes in an ethnically relatively 
homogenous population, for the purpose of studying the impact of family history 
on type 2 diabetes. The self-reported prevalence of a family history of diabetes was 
originally 22-25%. By the enrichment, the prevalence became 50%. Theoretically, 
the enrichment of a family history of diabetes would have caused a higher 
prevalence of type 2 diabetes in our study group, since family history of diabetes is 
a risk factor. However, the sole impact of a family history of diabetes is not that 
great. Other factors are involved: some of them having an even stronger influence 
on type 2 diabetes, like BMI. In addition, other circumstances may influence the 
prevalence of type 2 diabetes in the response- and non-response groups; for 
instance, the non-response group could have other diseases (that the responders do 
not have) that made them unwilling to participate, and which increases their risk for 
type 2 diabetes. We do not know the prevalence of a family history of diabetes in 
non-responders at the screening phase.  
 
In study IV, it was indicated that selective non-response was not present at the 
screening- and baseline steps since the prevalence of drug-treated diabetes was 
equal in responders and non-responders, while at follow-up selection bias to some 
extent seemed to have been introduced.  
 
 
5.2.5 Confounding 
An advantage in the present studies was that we had the opportunity to take many 
potential confounders into account. However, it is not possible to know if there are 
factors involved which are not measured (residual confounding). When studying 
the associations between exposures and disease, a confounder is a factor that is also 
associated with the disease. In addition, the confounder must be related to the 
exposure, however should not be an effect of the exposure38 . 
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5.3 GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
Extensive cohort and diabetes screening studies are costly to perform. However, 
screening leading to early diagnosis of diabetes is important, as early treatment 
reduces the risk of complications. In addition, etiological studies that can be carried 
out reveal insights in which factors or exposures that influence the risk of 
developing type 2 diabetes. This thesis demonstrates that initiatives such as the 
Stockholm Diabetes Prevention Program generates knowledge and most important, 
that the problem of non-response seems practically negligible. The SDPP forms a 
solid base for research which can be used to identify risk groups and design 
interventions that may be applied on different levels in society. 
 
Examples of further studies: 
• Evaluation of biologic interaction effects between risk factors for type 2 diabetes, 
using a prospective approach. 
• Analyses of psychological distress and depression influencing the risk of type 2 
diabetes, using validated instruments and taking into account duration of exposure, 
and if possible also sleep quality and quantity.  
• Studies identifying the biological mechanisms linking depression and sleep 
disturbances to type 2 diabetes.  
• Examination and follow-up of women with gestational diabetes. 
• Assessment of diabetes in non-European immigrants in Sweden and their specific 
risk factors, and possible prevention strategies. 
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6 CONCLUSIONS 
 
This thesis provides additional insights into the aetiology of type 2 diabetes in 
Swedish middle-aged men and women. The thesis confirms that a family history of 
diabetes is an important risk factor in men and women and that family history of 
diabetes does not obviously act in biologic synergy with other risk factors such as 
increased BMI, smoking or physical inactivity, or low sense of coherence. There is 
cross-sectional interaction between family history of diabetes and BMI in women.  
 
The studies also add to the accumulating evidence that psychological distress, in 
our study measured as self-reported symptoms of anxiety, apathy, depression, 
fatigue and insomnia, plays a role in the aetiology of type 2 diabetes, at least in 
men.  
 
The results suggest that personality factors may be associated with abnormal 
glucose regulation such as antagonism in men, and hedonic capacity in men and 
women, while others, such as impulsivity, negative affectivity, and alexithymia 
may not be associated with abnormal glucose regulation.  
 
In addition, the thesis demonstrates that a population-based cohort study on type 2 
diabetes including screening with OGTT, with high attendance rates, seems to 
provide accurate information regarding the prevalence at screening and baseline 
steps, however at follow-up, after having performed several steps, the sample may 
have been subjected to selection bias influencing the cumulative incidence. 
However, the effect of this in the association studies seems to be fairly limited. 
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